Informações:
Falhas:
ID
32933
Descrição
An Investigation Into Bone Micro-architecture in Women With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00982371
Link
https://clinicaltrials.gov/show/NCT00982371
Palavras-chave
Versões (1)
- 21/11/2018 21/11/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
21 de novembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes Mellitus NCT00982371
Eligibility Type 2 Diabetes Mellitus NCT00982371
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00982371
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Age
Item
>= 65 years old
boolean
C0001779 (UMLS CUI [1])
Postmenopausal state Duration
Item
postmenopausal for > 5 years (who definition of menopause)
boolean
C0232970 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Pharmaceutical Preparations Osteoporosis Related | Hormone replacement therapy | Selective Estrogen Receptor Modulators | Diphosphonates | Parathyroid Hormone | Calcitonin | Fluorides
Item
currently taking osteoporosis related medication (hrt, serm, bisphosphonate, pth, calcitonin, fluoride)
boolean
C0013227 (UMLS CUI [1,1])
C0029456 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0282402 (UMLS CUI [2])
C0732611 (UMLS CUI [3])
C0012544 (UMLS CUI [4])
C0030520 (UMLS CUI [5])
C0006668 (UMLS CUI [6])
C0016327 (UMLS CUI [7])
C0029456 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0282402 (UMLS CUI [2])
C0732611 (UMLS CUI [3])
C0012544 (UMLS CUI [4])
C0030520 (UMLS CUI [5])
C0006668 (UMLS CUI [6])
C0016327 (UMLS CUI [7])
Malignant Neoplasms | Secondary malignant neoplasm of bone Probably | Breast Carcinoma | Carcinoma of lung
Item
had cancer in past 10 years, likely to metastasize to bone (ie: breast, lung)
boolean
C0006826 (UMLS CUI [1])
C0153690 (UMLS CUI [2,1])
C0750492 (UMLS CUI [2,2])
C0678222 (UMLS CUI [3])
C0684249 (UMLS CUI [4])
C0153690 (UMLS CUI [2,1])
C0750492 (UMLS CUI [2,2])
C0678222 (UMLS CUI [3])
C0684249 (UMLS CUI [4])
Bone Diseases Intrinsic | Paget's disease of bone | Cushing Syndrome
Item
have intrinsic bone disease (ie: paget's disease, cushings syndrome)
boolean
C0005940 (UMLS CUI [1,1])
C0205102 (UMLS CUI [1,2])
C0029401 (UMLS CUI [2])
C0010481 (UMLS CUI [3])
C0205102 (UMLS CUI [1,2])
C0029401 (UMLS CUI [2])
C0010481 (UMLS CUI [3])
Malabsorption Syndrome Untreated | Celiac Disease
Item
have untreated malabsorption syndrome (ie: celiac disease)
boolean
C0024523 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0007570 (UMLS CUI [2])
C0332155 (UMLS CUI [1,2])
C0007570 (UMLS CUI [2])
Renal Insufficiency | Creatinine clearance measurement
Item
renal insufficiency (crcl <30ml/min)
boolean
C1565489 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0373595 (UMLS CUI [2])
Hyperparathyroidism | Hypoparathyroidism
Item
hyperparathyroidism, hypoparathyroidism
boolean
C0020502 (UMLS CUI [1])
C0020626 (UMLS CUI [2])
C0020626 (UMLS CUI [2])
Systemic Glucocorticoids chronic Dose U/day
Item
chronic systemic glucocorticosteroid use > 3mos, dose>2.5mg daily
boolean
C3540777 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0205191 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])